Literature DB >> 22907578

[Prediction of the reaction of normal tissue and tumor cells to radiotherapy].

E Dikomey1, J Dahm-Daphi, L Distel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22907578     DOI： 10.1007/s00066-012-0204-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  49 in total

1.  Biochemical evidence for Ku-independent backup pathways of NHEJ.

Authors:  Huichen Wang; Ange Ronel Perrault; Yoshihiko Takeda; Wei Qin; Hongyan Wang; George Iliakis
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

2.  A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivity.

Authors:  Markus A Schirmer; Jürgen Brockmöller; Margret Rave-Fränk; Patricia Virsik; Barbara Wilken; Elna Kühnle; Radu Campean; Arne O Hoffmann; Katarina Müller; Robert G Goetze; Michael Neumann; Jörg H Janke; Fatima Nasser; Hendrik A Wolff; B Michael Ghadimi; Heinz Schmidberger; Clemens F Hess; Hans Christiansen; Andrea Hille
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-22       Impact factor: 7.038

3.  Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.

Authors:  Kerstin Borgmann; Ulrike Hoeller; Sven Nowack; Michael Bernhard; Barbara Röper; Sophie Brackrock; Cordula Petersen; Silke Szymczak; Andreas Ziegler; Petra Feyer; Winfried Alberti; Ekkehard Dikomey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

Review 4.  Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways.

Authors:  Emil Mladenov; George Iliakis
Journal:  Mutat Res       Date:  2011-02-15       Impact factor: 2.433

5.  Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses.

Authors:  Kai Rothkamm; Markus Löbrich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

6.  Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.

Authors:  Apostolos Menegakis; Wolfgang Eicheler; Ala Yaromina; Howard D Thames; Mechthild Krause; Michael Baumann
Journal:  Radiother Oncol       Date:  2011-08-05       Impact factor: 6.280

7.  Joining of correct and incorrect DNA double-strand break ends in normal human and ataxia telangiectasia fibroblasts.

Authors:  M Löbrich; M Kühne; J Wetzel; K Rothkamm
Journal:  Genes Chromosomes Cancer       Date:  2000-01       Impact factor: 5.006

8.  Impact of stromal sensitivity on radiation response of tumors.

Authors:  W Budach; A Taghian; J Freeman; D Gioioso; H D Suit
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

9.  Prediction of tumor radiosensitivity in rectal carcinoma based on p53 and Ku70 expression.

Authors:  Y Komuro; T Watanabe; Y Hosoi; Y Matsumoto; K Nakagawa; S Saito; S Ishihara; S Kazama; N Tsuno; J Kitayama; N Suzuki; G Tsurita; T Muto; H Nagawa
Journal:  J Exp Clin Cancer Res       Date:  2003-06

10.  Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy.

Authors:  Dorothee Twardella; Odilia Popanda; Irmgard Helmbold; Reinhard Ebbeler; Axel Benner; Dietrich von Fournier; Wulf Haase; Marie Luise Sautter-Bihl; Frederik Wenz; Peter Schmezer; Jenny Chang-Claude
Journal:  Radiother Oncol       Date:  2003-11       Impact factor: 6.280
View more
  1 in total

1.  Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity.

Authors:  Sebastian Reuther; Silke Szymczak; Annette Raabe; Kerstin Borgmann; Andreas Ziegler; Cordula Petersen; Ekkehard Dikomey; Ulrike Hoeller
Journal:  Strahlenther Onkol       Date:  2014-08-26       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.